Author

Verena Thewes

German Cancer Research CenterORCID 0009-0004-6006-4636Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1 Assay:metabolomics· 1

Frequent Co-Authors

Christoph StangeiD· 2 shared Peter LichteriD· 2 shared Adriano B Chaves-Filho· 1 shared Albrecht StenzingeriD· 1 shared Alina M. WinkelkotteiD· 1 shared Almut SchulzeiD· 1 shared Amirhossein SakhtemaniD· 1 shared Anderas Schneeweiss· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Christoph StangeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Catabolism of extracellular glutathione is a driver of metastasis formation

Felix C. E. Vogel, Florian Roehrig, Danny Schilling, Adriano B Chaves-Filho, Greta Mattavelli, Maximilian Kraemer, Julie Haenlin, Alina M. Winkelkotte, Valentine Fournier, Kamal M. Al-Shami, H. Rohdjeß, Philipp Poeller, Tanja Poth, Christoph Stange, Bernhard Kuester, , Almut Schulze

The paper identifies extracellular glutathione catabolism as a driver of metastasis by enabling proliferation and oxidative stress resistance in metabolically challenging microenvironments.

bioRxiv · Oct 13, 2026 · PreprintCancer Biology

Prospective pan-cancer phosphoproteomics at clinical scale extends therapeutic options in precision oncology

Annika Schneider, Julia Wortmann, Cecilia Bang Jensen, Leonardo Estrada Duenas, Maria‐Veronica Teleanu, Amirhossein Sakhteman, Firas Hamood, Florian P Bayer, Christoph Stange, Jeremiah Bintang Santoso, Jennifer Hüellein, Nindo B. Punturi, Lee Dolat, Peter Horak, Resch Moritz, , Bernhard Küster

This study uses pan-cancer phosphoproteomics to identify therapeutic targets and improve precision oncology by analyzing 1,998 tumor samples and developing new scores for kinase activity and immune response.

bioRxiv · Jul 9, 2026 · PreprintCancer Biology